The placenta is the link between mother and baby during pregnancy. Two arteries and one vein in the umbilical cord carry blood back and forth. If the newborn baby is ill right after birth, a catheter may be placed. Due to increasing premature births, probability of baby being born unhealthy is also increasing. Moreover, the neonatal care is being advocated by governments globally and hence is increasing. These factors have resulted in growth of the umbilical vessel catheter market.
Key Market Trends
Umbilical Venous Catheter (UVC) is expected to register high growth in the forecast period
An UVC allows fluids and medicines to be given without frequently replacing an intravenous (IV) line. An UVC is used when the baby is very premature, has bowel problems that prevent feeding, needs very strong medicines or needs exchange transfusion.
The demand for UVC is expected to rise due to increasing preterm births even is more developed part of the world. As per Center for Diseases Control and Prevention 2018 data, the total preterm births rates have been increasing gradually over the years in the United States of America (US). The data observed that this rate was 9.57 in 2014 which increased to 9.85 in 2016 in the US. Rise in preterm births will require neonatal care, for which UVC is a vital instrument. Hence, the market for UVC is expected to grow.
North America dominates the market
The United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players.
Moreover, the demand for Umbilical Vessel Catheters is high in the region due to high and increasing preterm births. As per a 2019 article in Canadian Institutes of Health Research, preterm births in Canada have increased by 20% during the past two decades. In Mexico as well, nearly 200,000 babies are born prematurely, as per 2017 data by Ministry of Health in Mexico. These factors have been driving the market growth in the region.
Majority of the Umbilical Vessel Catheters are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market growth.
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Study Assumptions
1.3 Scope of the Study
4.2 Market Drivers
4.2.1 Increasing Neonatal Care Globally
4.2.2 Inrcreasing number of Premature Births
4.3 Market Restraints
4.3.1 High Cost of Catheters
4.3.2 Lack of Skilled Professionals
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1.1 Umbilical Venous Catheter
5.1.2 Umbilical Artery Catheter
5.2 By End-User
5.3.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
126.96.36.199 South Africa
188.8.131.52 Rest of Middle East and Africa
5.3.5 South America
184.108.40.206 Rest of South America
6.1.1 SURU International Pvt. Ltd.
6.1.2 Cardinal Health, Inc.
6.1.3 Vygon SA
6.1.4 Utah Medical Products, Inc.
6.1.5 Hummingbird Medical
A selection of companies mentioned in this report includes:
- SURU International Pvt. Ltd.
- Cardinal Health, Inc.
- Vygon SA
- Utah Medical Products, Inc.
- Hummingbird Medical